The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation - Wikidata - awgldk - TriplyDB

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

http://www.wikidata.org/entity/Q36393201

about

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations Influence of gender and age on the survival of patients with nasopharyngeal carcinoma Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?Androgen receptor as a targeted therapy for breast cancer.The Role of Androgen Receptor in Breast Cancer.Effect of Gonadectomy on the Androgen-Dependent Behavior of Ganglion Cell-Like Cells in Djungarian Hamsters (Phodopus sungorus).Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin.Sex hormone receptor repertoire in breast cancer.Androgen receptor-mediated apoptosis in bovine testicular induced pluripotent stem cells in response to phthalate esters.Bovine induced pluripotent stem cells are more resistant to apoptosis than testicular cells in response to mono-(2-ethylhexyl) phthalate.AR Signaling in Breast Cancer.Postmenopausal breast cancer, androgens, and aromatase inhibitors.The role of the androgen receptor in triple-negative breast cancer.Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.Cooperative Dynamics of AR and ER Activity in Breast Cancer.Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms.Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort.Post-menopausal breast cancer: from estrogen to androgen receptor.Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.

P2860

Q21195191-039C409F-7974-4983-9B48-8603632C5CE5 Q33814367-B3D9B236-16F6-495F-A61E-CF3D2B4749AD Q34309894-EDFA06B5-19EF-4491-9349-49768C7774A4 Q34705381-C057CC98-3B44-4550-9EBE-AB46AF1E7660 Q35892429-2003E7C9-4D72-41A8-A8C8-83AD6D592BA9 Q36135807-038BA6F6-D2B7-425C-8CF5-8ED88CA55F86 Q36275556-103FC3B7-2985-4433-A459-4EBED9520347 Q36575662-57FC6FED-F675-4CFC-9F53-5314D7191728 Q36678527-AAFBCD91-EFD1-4DE9-9F4C-3F21350888B1 Q36687211-2E2C70F0-4D32-4AD7-BDE2-CE0448D7434F Q36908403-54CEC689-BFD8-4B34-8F91-2F6952A2D1B3 Q37269053-C4998863-CC87-4E7E-B8AE-03AA3E90D62B Q37353645-57BBD1A1-E4A3-4F5B-B4A7-ABC50A40CD9B Q37357034-2FA410DD-7C28-4D79-8F91-3271E978B901 Q37684138-9AA1EE40-47EB-45CA-B2B9-EE1B0B5F85A6 Q37721492-80BEC443-9D27-4650-B96A-ED9401BC09BB Q38097730-2527219B-14A4-4898-871E-63D2CA67CAFD Q38119251-32C87192-C1EA-4396-8553-53AF8523FF21 Q38552128-E6204D49-E629-48A7-83A4-24FA2609B5DD Q38749913-B351377C-D97E-4045-BD6F-DC12A5DFD5AF Q40453986-B1ACC5BE-0C99-44CA-A8E8-38BB5F693439 Q44103718-86882AE3-6B10-4A8A-8FC1-C2C3CCF5C709 Q47094109-184B4369-9B14-4F23-858A-7784B638ABC4 Q55170957-13C2283F-204C-4B42-A56D-E57AF399305F

P2860

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

http://www.wikidata.org/entity/Q36393201

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

The growth response to androge ...... nd mediated by MAPK activation

@ast

The growth response to androge ...... nd mediated by MAPK activation

@en

type

label

The growth response to androge ...... nd mediated by MAPK activation

@ast

The growth response to androge ...... nd mediated by MAPK activation

@en

prefLabel

The growth response to androge ...... nd mediated by MAPK activation

@ast

The growth response to androge ...... nd mediated by MAPK activation

@en

P1433

Q36393201-7A3D803F-8457-4D23-9BA7-3C590ECE0B99

P1476

Q36393201-CD52A126-E99D-4C83-A09F-287A2576DF1B

P2093

Q36393201-0217DCE9-345C-48E1-8B05-9F9093B3441E

Q36393201-0449BE58-4511-4535-BE3B-DC5391041BDA

Q36393201-13D7F7B0-0B0F-4D33-ADBE-37E7E7B7970E

Q36393201-15FCA541-1879-42BB-9E93-C6BA7AD6BE14

Q36393201-1A5A74FA-30BD-49F6-921A-E764B5A2ABBA

Q36393201-1D1E14C4-B85E-45F7-BEC7-562BF5FD4C1A

Q36393201-1EF37348-162D-4A94-8455-5C2ADD8F45AF

Q36393201-3E0665A3-2153-4DF2-B0AC-C34A6295A977

Q36393201-41A06D3C-3BAA-417B-992D-DA69ED9EDA89

Q36393201-444DB2A9-4578-4020-96B5-C8EF0B67876C

P2860

Q36393201-01A37BA1-324D-4C6B-8724-712B9DFD61DF

Q36393201-051996DE-9490-4385-9808-FCF665648766

Q36393201-05CF2C37-F82D-4AEB-9754-ACA5E195A72C

Q36393201-09DE2AF9-8FC6-4061-AEB5-29BBDA8ECB0A

Q36393201-11FE5B9F-D66D-408C-9010-2FFF44345875

Q36393201-14ADD934-464B-43C1-A519-531AD19D2379

Q36393201-15E7E4F2-B143-4A4F-8793-77D6B3536495

Q36393201-1823F338-C931-477A-94F6-D65123A0C562

Q36393201-1E28644C-5391-469B-802F-D1078A9ED802

Q36393201-29D78DE6-E202-484D-8EAC-FC1221223A26

P2888

Q36393201-B9AABE5F-D5B3-4EFA-880F-55592951FB5E

P304

Q36393201-0B58E0CD-58D5-47AB-A70D-59CE98D6748F

P31

Q36393201-7352D094-97D0-42DF-BF90-4A86E5417910

P356

Q36393201-1BEF7654-1B28-48B2-A8D1-891E116D15E9

P433

Q36393201-F1BF0DC7-645E-4C07-B33B-249C7BB2F5B6

P478

Q36393201-5A730D19-F065-4B66-A98B-ED052B123241

P577

Q36393201-1AB11E75-05AB-4A86-8C2B-310C404B947E

P5875

Q36393201-BAE8C979-4CB3-4D1A-8B2E-32DF7086858D

P6179

Q36393201-0CCC102D-EF04-405D-A8C4-EF29FCE76398

P698

Q36393201-A1C4D8E7-93A4-47E2-BEC1-35B568C1904E

P932

Q36393201-EDE80782-1437-4CB6-9D3B-720C450F2066

P356

P1433

Breast Cancer Research

P1476

The growth response to androge ...... nd mediated by MAPK activation

@en

P2093

Abde M Abukhdeir

http://www.w3.org/2001/XMLSchema#string

Alan Meeker

http://www.w3.org/2001/XMLSchema#string

Andrea Subhawong

http://www.w3.org/2001/XMLSchema#string

Angelo M De Marzo

http://www.w3.org/2001/XMLSchema#string

Antoun Toubaji

http://www.w3.org/2001/XMLSchema#string

Ashani Weeraratna

http://www.w3.org/2001/XMLSchema#string

Bedri Karakas

http://www.w3.org/2001/XMLSchema#string

Ben H Park

http://www.w3.org/2001/XMLSchema#string

Cheryl A Sherman Baust

http://www.w3.org/2001/XMLSchema#string

Danijela Jelovac

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting androgen receptor in estrogen receptor-negative breast cancer

The program of androgen-responsive genes in neoplastic prostate epithelium.

Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling

WAF1, a potential mediator of p53 tumor suppression

A mechanism for cell-cycle regulation of MAP kinase signaling in a yeast differentiation pathway.

Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor.

Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group.

P2888

P304

R27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3112

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221820548

http://www.w3.org/2001/XMLSchema#string

P6179

1046357597

http://www.w3.org/2001/XMLSchema#string

P698

22321971

http://www.w3.org/2001/XMLSchema#string

P932

3496145

http://www.w3.org/2001/XMLSchema#string